Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dagher, Christine
NCT04870541: Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering.	Recruiting	4	150	RoW	Ondansetron 8mg, Nefopam Injectable Solution	Saint-Joseph University	Shivering, Adverse Effects in the Therapeutic Use of Anaesthetic	06/21	12/21